Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after...

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Medical Device Technology

Background:

• In-stent restenosis (ISR) is a significant complication following bare-metal stenting, primarily driven by intimal hyperplasia (IH).
• The number of circulating vascular progenitor cells (VPCs) post-stenting correlates with IH development.
• Predictive markers for IH remain crucial for patient management.

Purpose of the Study:

• To investigate whether the differentiation profile of VPCs can predict the development and severity of IH after bare-metal stenting.
• To identify specific VPC phenotypes associated with IH.
• To assess the additive value of VPC differentiation profiles to traditional risk factors for predicting IH.

Main Methods:

• Peripheral blood was collected from 58 patients post-stenting for VPC culture.
• VPC differentiation into endothelial (VE-cadherin positive) and smooth muscle (α-smooth muscle actin positive) lineages was assessed via flow cytometry.
• Intravascular ultrasound quantified IH area 6 months post-stenting.

Main Results:

• VPCs differentiated into four distinct phenotypes: α-SMA(-)VE-Cad(+), α-SMA(+)VE-cad(high), α-SMA(+)VE-cad(low), and α-SMA(+)VE-Cad(-).
• IH was significantly correlated with gender, smoking status, reference vessel diameter, minimal lumen diameter, stent area, and VPC differentiation parameters.
• Multivariate analysis identified the number of α-SMA(+)VE-Cad (low/-) VPCs and the ratio of α-SMA(+)VE-Cad (low/-) to α-SMA(-)VE-Cad(+) VPCs as independent predictors of IH, even after controlling for stent area, smoking, and gender.

Conclusions:

• The differentiation profile of VPCs independently predicts the severity of post-stent IH.
• Specific VPC phenotypes, particularly α-SMA(+)VE-Cad (low/-) cells, are strongly associated with IH development.
• VPC differentiation profiling offers a potential future tool for identifying patients at high risk of post-stent restenosis.